SANCHE BELL: Open Payments
NPI 1326644659 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 33 payments from 14 companies in 2025. Trend: 2023 $514 · 2024 $1,140 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $117 |
| ABBVIE INC. | 4 | $86 |
| Phathom Pharmaceuticals, Inc. | 4 | $80 |
| Lilly USA, LLC | 4 | $75 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Corcept Therapeutics | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: VRAYLAR, VOQUEZNA, MOUNJARO, TRELEGY ELLIPTA, GEMTESA, GARDASIL 9, Ozempic, Korlym.
Industry payments across FL — which companies pay providers there.
